A detailed history of Point72 (Difc) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 12,788 shares of VCYT stock, worth $497,964. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,788
Previous 10,010 27.75%
Holding current value
$497,964
Previous $217 Million 100.68%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $58,338 - $97,924
2,778 Added 27.75%
12,788 $435 Million
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $188,788 - $235,735
10,010 New
10,010 $217 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.79B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.